BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of ...

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

The increased genetic complexity and similarity to adult cancers’ genetic diversity could also present new therapeutic opportunities.

In this GEN webinar, Gerben Zijlstra, PhD, and Jean-Marc Cappia, both experts in process intensification, explore the ...

Proteins represent 95% of drug targets designed to combat disease, according to Yvonne Tan, PhD, from Nuclera.

The first systematic genome-wide association study for pseudogout has identified two genes strongly associated with disease ...

Using neem tree extracts as a starting point, scientists have created several kinds of nanozymes and tested them for ...

A scientist says he has shown that it’s possible to produce a large amount of virus-like particles using a fully scalable ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...